Antiviral therapy to reduce hepatocellular carcinoma recurrence in patients with low HBV-DNA levels: A randomized controlled trial.
Gang Huang(Shanghai Jiao Tong University), Weiping Zhou(Second Military Medical University), Linghao Zhao(Second Military Medical University), Meng‐chao Wang(Ministry of Education of the People's Republic of China), Pengpeng Li(Boston Children's Hospital), Ze‐Ya Pan(Second Military Medical University), Zhenguang Wang(Beijing Institute of Technology), Wan Yee Lau(Chinese University of Hong Kong)
Cited by 0
Related Papers
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2005|591
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
|PubMed|1999|519